Filgrastim Vial is a medication containing a hematopoietic growth factor (HGF) in each vial. This medication is used to help reduce the risk of infection in certain patients with a deficiency of white blood cells called neutropenia. These patients include cancer patients receiving chemotherapy that suppresses bone marrow and bone marrow transplant patients whose white blood cell production is low. The medication works by stimulating the bone marrow to produce more neutrophils, an important type of white blood cell that plays a crucial role in fighting bacterial and fungal infections.
What are the ingredients in Filgrastim?
Filgrastim Vial contains the following active ingredient:
recombinant human granulocyte colony stimulating factor: 300 mcg per vial.
Filgrastim is usually available as a sterile solution for injection. The solution may also contain inactive ingredients to maintain drug stability. No other strengths or forms of this product are available, according to available information.
Indications for Use of Filgrastim
Filgrastim Vial is used in the following cases:
Reducing the duration of acute neutropenia in patients receiving myelosuppressive chemotherapy for cancer treatment.
Reducing the duration of neutropenia and accelerating neutrophil recovery in patients undergoing autologous or allogeneic bone marrow transplantation.
Mobilizing peripheral blood hematopoietic stem cells for collection and use in autologous bone marrow transplantation.
Treatment of severe chronic neutropenia, including congenital, recurrent, and acquired neutropenia.
Treatment of persistent neutropenia in patients with advanced human immunodeficiency virus (HIV) to reduce the risk of bacterial infections.
What is the dosage of Filgrastim?
The dosage, route of administration, and duration of treatment are determined by the physician based on the patient's medical condition, the type of treatment they are receiving, and their neutrophil count.
Filgrastim is usually injected subcutaneously (subcutaneously) or intravenously (intravenously).
The dosage depends on the indication and may vary significantly between patients. Injections are usually given daily until the neutrophil count reaches the desired level.
Patients or their healthcare providers should learn the correct injection method. Blood counts are monitored regularly to assess the patient's response to treatment and adjust the dose if necessary.
What are the side effects of filgrastim?
It may cause some side effects, including:
Bone pain.
Headache.
Fatigue.
Nausea and vomiting.
Temporary hair loss.
Elevated liver enzymes.
Pain at the injection site.